Reporting Manager
TANG CAPITAL MANAGEMENT, LLC
Symbol
CMPX
Shares outstanding
137,037,037 shares
Disclosed Ownership
7,400,000 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
16 Jan 2025, 17:17:38 UTC
Date of event
08 Jan 2025
Next filing
15 May 2025

Quoteable Key Fact

"TANG CAPITAL MANAGEMENT LLC disclosed 5.4% ownership in Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX) on 08 Jan 2025."

Quick Takeaways

  • TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share (CMPX).
  • Disclosed ownership: 5.4%.
  • Date of event: 08 Jan 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Jan 2025, 17:17.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
TANG CAPITAL MANAGEMENT, LLC 5.4% 7,400,000 0 7,400,000 /s/ Kevin Tang Manager
KEVIN TANG 5.4% 7,400,000 0 7,400,000 /s/ Kevin Tang Self
TANG CAPITAL PARTNERS, LP 3.4% 4,669,934 0 4,669,934 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS INTERNATIONAL, LP 2% 2,730,066 0 2,730,066 /s/ Kevin Tang Manager, Tang Capital Management, LLC, General Partner
TANG CAPITAL PARTNERS III, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer
TANG CAPITAL PARTNERS IV, INC 0% 0 0 0 /s/ Kevin Tang Chief Executive Officer